Journal of Family Medicine and Primary Care

COMMENTARY
Year
: 2020  |  Volume : 9  |  Issue : 9  |  Page : 4512--4515

COVID 19 and diabetes: An endocrinologist's perspective


Kishore K Behera1, Debasish Hota2, Ashoka Mahapatra3 
1 Department of Endocrinology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
2 Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
3 Department of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India

Correspondence Address:
Dr. Kishore K Behera
Department of Endocrinology, All India Institute of Medical Sciences, Bhubaneswar - 751 019
India

The clinical manifestation of COVID-19 is diverse, oscillating from mild flu-like symptoms to more severe outcome, such as acute respiratory distress syndrome, multiple organ failure, and death. Advanced age and comorbidities, such as diabetes mellitus, high blood pressure, and history of cerebrovascular accidents are reported to have worse outcome. Chronic inflammation by cytokine storm and direct insult to pancreatic by COVID-19 might be postulated mechanisms of inducing or deteriorating diabetes. Individualized patient-centric treatment and optimal blood sugar control should be made based on disease severity, presence of comorbid condition, and complications related to diabetes, age, and other risk factors. Recent clinical trials have shown some hope to anti-interleukin antibody as a potential therapeutic option against COVID-19 especially in people with severe illness.


How to cite this article:
Behera KK, Hota D, Mahapatra A. COVID 19 and diabetes: An endocrinologist's perspective.J Family Med Prim Care 2020;9:4512-4515


How to cite this URL:
Behera KK, Hota D, Mahapatra A. COVID 19 and diabetes: An endocrinologist's perspective. J Family Med Prim Care [serial online] 2020 [cited 2020 Oct 25 ];9:4512-4515
Available from: https://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=9;spage=4512;epage=4515;aulast=Behera;type=0